Literature DB >> 20420909

The functions of key residues in the inhibitor, substrate and cofactor sites of human 3beta-hydroxysteroid dehydrogenase type 1 are validated by mutagenesis.

James L Thomas1, Vance L Mack, Jingping Sun, J Ross Terrell, Kevin M Bucholtz.   

Abstract

In postmenopausal women, human 3beta-hydroxysteroid dehydrogenase type 1 (3beta-HSD1) is a critical enzyme in the conversion of DHEA to estradiol in breast tumors, while 3beta-HSD2 participates in the production of cortisol and aldosterone in the human adrenal gland. The goals of this project are to determine if Arg195 in 3beta-HSD1 vs. Pro195 in 3beta-HSD2 in the substrate/inhibitor binding site is a critical structural difference responsible for the higher affinity of 3beta-HSD1 for inhibitor and substrate steroids compared to 3beta-HSD2 and whether Asp61, Glu192 and Thr8 are fingerprint residues for cofactor and substrate binding using site-directed mutagenesis. The R195P-1 mutant of 3beta-HSD1 and the P195R-2 mutant of 3beta-HSD2 have been created, expressed, purified and characterized kinetically. Dixon analyses of the inhibition of the R195P-1 mutant, P195R-2 mutant, wild-type 3beta-HSD1 and wild-type 3beta-HSD2 by trilostane has produced kinetic profiles that show inhibition of 3beta-HSD1 by trilostane (K(i)=0.10microM, competitive) with a 16-fold lower K(i) and different mode than measured for 3beta-HSD2 (K(i)=1.60microM, noncompetitive). The R195P-1 mutation shifts the high-affinity, competitive inhibition profile of 3beta-HSD1 to a low-affinity (trilostane K(i)=2.56microM), noncompetitive inhibition profile similar to that of 3beta-HSD2 containing Pro195. The P195R-2 mutation shifts the low-affinity, noncompetitive inhibition profile of 3beta-HSD2 to a high-affinity (trilostane K(i)=0.19microM), competitive inhibition profile similar to that of 3beta-HSD1 containing Arg195. Michaelis-Menten kinetics for DHEA, 16beta-hydroxy-DHEA and 16alpha-hydroxy-DHEA substrate utilization by the R195P-1 and P195R-2 enzymes provide further validation for higher affinity binding due to Arg195 in 3beta-HSD1. Comparisons of the Michaelis-Menten values of cofactor and substrate for the targeted mutants of 3beta-HSD1 (D61N, D61V, E192A, T8A) clarify the functions of these residues as well. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420909      PMCID: PMC2891085          DOI: 10.1016/j.jsbmb.2010.04.015

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  24 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase: purification from microsomes, substrate kinetics, and inhibition by product steroids.

Authors:  J L Thomas; E A Berko; A Faustino; R P Myers; R C Strickler
Journal:  J Steroid Biochem       Date:  1988-11       Impact factor: 4.292

3.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

4.  Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3 beta-hydroxysteroid dehydrogenase/isomerase.

Authors:  James L Thomas; William L Duax; Anthony Addlagatta; Stacey Brandt; Robert R Fuller; Wendy Norris
Journal:  J Biol Chem       Date:  2003-06-27       Impact factor: 5.157

5.  Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.

Authors:  E Rhéaume; Y Lachance; H F Zhao; N Breton; M Dumont; Y de Launoit; C Trudel; V Luu-The; J Simard; F Labrie
Journal:  Mol Endocrinol       Date:  1991-08

6.  Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes.

Authors:  J L Thomas; R P Myers; R C Strickler
Journal:  J Steroid Biochem       Date:  1989-08       Impact factor: 4.292

7.  Cofactor hydrogen bonding onto the protein main chain is conserved in the short chain dehydrogenase/reductase family and contributes to nicotinamide orientation.

Authors:  Rong Shi; Sheng-Xiang Lin
Journal:  J Biol Chem       Date:  2004-02-13       Impact factor: 5.157

8.  Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli.

Authors:  J B Thoden; P A Frey; H M Holden
Journal:  Biochemistry       Date:  1996-02-27       Impact factor: 3.162

Review 9.  Short-chain dehydrogenases/reductases (SDR).

Authors:  H Jörnvall; B Persson; M Krook; S Atrian; R Gonzàlez-Duarte; J Jeffery; D Ghosh
Journal:  Biochemistry       Date:  1995-05-09       Impact factor: 3.162

10.  Serine 124 completes the Tyr, Lys and Ser triad responsible for the catalysis of human type 1 3beta-hydroxysteroid dehydrogenase.

Authors:  J L Thomas; W L Duax; A Addlagatta; L A Scaccia; K A Frizzell; S B Carloni
Journal:  J Mol Endocrinol       Date:  2004-08       Impact factor: 5.098

View more
  5 in total

1.  Inner mitochondrial translocase Tim50 interacts with 3β-hydroxysteroid dehydrogenase type 2 to regulate adrenal and gonadal steroidogenesis.

Authors:  Kevin J Pawlak; Manoj Prasad; James L Thomas; Randy M Whittal; Himangshu S Bose
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Lipid-mediated unfolding of 3β-hydroxysteroid dehydrogenase 2 is essential for steroidogenic activity.

Authors:  Maheshinie Rajapaksha; James L Thomas; Michael Streeter; Manoj Prasad; Randy M Whittal; John D Bell; Himangshu S Bose
Journal:  Biochemistry       Date:  2011-12-06       Impact factor: 3.162

Review 3.  Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer.

Authors:  James L Thomas; Kevin M Bucholtz; Balint Kacsoh
Journal:  J Steroid Biochem Mol Biol       Date:  2010-08-22       Impact factor: 4.292

4.  Ile258Met mutation of Brucella melitensis 7α-hydroxysteroid dehydrogenase significantly enhances catalytic efficiency, cofactor affinity, and thermostability.

Authors:  Zhiyong Liu; Rongzhen Zhang; Wenchi Zhang; Yan Xu
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 4.813

5.  Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids.

Authors:  Renate Louw-du Toit; Meghan S Perkins; Jacky L Snoep; Karl-Heinz Storbeck; Donita Africander
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.